Lynne Bui
Direktor/Vorstandsmitglied bei THARIMMUNE, INC.
Vermögen: - $ am 31.05.2024
Aktive Positionen von Lynne Bui
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| THARIMMUNE, INC. | Direktor/Vorstandsmitglied | 01.07.2021 | - |
| Independent Dir/Board Member | 01.07.2021 | - | |
Khloris Biosciences, Inc.
 Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA. | Vorstandsvorsitzender | 01.06.2017 | - |
| Gründer | - | - | |
| Präsident | 01.06.2017 | - | |
| Global Cancer Research Institute | Vorsitzender | - | - |
| Gründer | - | - | |
| GCRI Foundation, Inc. | Vorsitzender | - | - |
| Gründer | - | - |
Karriereverlauf von Lynne Bui
Ehemalige bekannte Positionen von Lynne Bui
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Intellikine LLC
 Intellikine LLC Pharmaceuticals: MajorHealth Technology Intellikine LLC develops and manufactures small molecule drugs for the treatment of cancer. The company focused on the development of potent, selective small molecule inhibitors of the PI3K/Akt/mTOR pathway for the treatment of cancer, inflammation and autoimmune disorders. Intellikine was founded on May 2nd, 2007 and is headquartered in La Jolla, CA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| EXELIXIS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Lynne Bui
| University of California, Berkeley | Undergraduate Degree |
| David Geffen School of Medicine | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
| 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Founder | 3 |
| Chairman | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Khloris Biosciences, Inc.
Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA. | Commercial Services |
| Tharimmune, Inc. | |
| Global Cancer Research Institute | |
| GCRI Foundation, Inc. | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Intellikine LLC
Intellikine LLC Pharmaceuticals: MajorHealth Technology Intellikine LLC develops and manufactures small molecule drugs for the treatment of cancer. The company focused on the development of potent, selective small molecule inhibitors of the PI3K/Akt/mTOR pathway for the treatment of cancer, inflammation and autoimmune disorders. Intellikine was founded on May 2nd, 2007 and is headquartered in La Jolla, CA. | Health Technology |
